United Kingdom Hip Reconstruction Market Outlook to 2025
June 2018
56
About the Report
About the Report
United Kingdom Hip Reconstruction Market Outlook to 2025
Summary
GlobalData's new report, United Kingdom Hip Reconstruction Market Outlook to 2025, provides key market data on the United Kingdom Hip Reconstruction market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Hip Resurfacing, Partial Hip Replacement, Primary Hip Replacement and Revision Hip Replacement.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Hip Reconstruction market categories-Hip Resurfacing, Partial Hip Replacement, Primary Hip Replacement and Revision Hip Replacement.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Hip Reconstruction market.
- Global corporate-level profiles of key companies operating within the United Kingdom Hip Reconstruction market.
- Key players covered include Stryker Corp, Zimmer Biomet Holdings Inc, DePuy Synthes Inc and Others.
Reasons to buy
- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Products
Products
Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag
Companies
Zimmer Biomet Holdings Inc
DePuy Synthes Inc
Stryker Corp
Corin Group PLC
Smith & Nephew Plc
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Hip Reconstruction Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Hip Reconstruction Market, United Kingdom 7
3.1 Hip Reconstruction Market, United Kingdom, Revenue (USDm), 2015-2025 7
3.1.1 Partial Hip Replacement Market, United Kingdom, Revenue (USDm), by Segment, 2015-2025 9
3.1.2 Primary Hip Replacement Market, United Kingdom, Revenue (USDm), by Segment, 2015-2025 11
3.2 Hip Reconstruction Market, United Kingdom, Volume (Units), 2015-2025 13
3.2.1 Partial Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2015-2025 15
3.2.2 Primary Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2015-2025 17
3.3 Hip Reconstruction Market, United Kingdom, Average Price (USD), 2015-2025 19
3.4 Hip Reconstruction Market, United Kingdom, Distribution Share by Revenue (USDm), 2017 21
3.5 Hip Reconstruction Market, United Kingdom, Company Share by Revenue (USDm), 2017 22
4 Overview of Key Companies in United Kingdom, Hip Reconstruction Market 24
4.1 Zimmer Biomet Holdings Inc 24
4.1.1 Company Overview 24
4.2 DePuy Synthes Inc 24
4.2.1 Company Overview 24
4.3 Stryker Corp 24
4.3.1 Company Overview 24
4.4 Corin Group PLC 24
4.4.1 Company Overview 24
4.5 Smith & Nephew Plc 25
4.5.1 Company Overview 25
5 Hip Reconstruction Market Pipeline Products 26
6 Financial Deals Landscape 27
6.1 Acquisition 27
6.1.1 AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million 27
6.2 Private Equity 29
6.2.1 Apposite Capital Acquries OrthoD from Riverside 29
6.2.2 Elliott Management May Acquire Stake in Smith & Nephew 31
7 Recent Developments 32
7.1 Corporate Communications 32
7.1.1 May 08, 2018: Smith & Nephew: Change of Directorate 32
7.1.2 Apr 05, 2018: ADAPT Pharma Welcomes Surgeon General Naloxone Advisory 32
7.1.3 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew 33
7.1.4 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth 34
7.1.5 Mar 01, 2018: Smith & Nephew: Change in Directorate 34
7.1.6 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director 35
7.1.7 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director 35
7.1.8 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 35
7.1.9 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer's intention to retire by end of 2018 36
7.1.10 Oct 09, 2017: Notice of Chief Executive Officer's intention to retire by end of 2018 36
7.1.11 Oct 02, 2017: Smith & Nephew Announces Directorate Change 37
7.1.12 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors 37
7.1.13 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 37
7.1.14 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 37
7.2 Financial Announcements 38
7.2.1 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report 38
7.2.2 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results 39
7.2.3 Jan 08, 2018: BerGenBio to present at Biotech Showcase 2018 40
7.2.4 Nov 06, 2017: KemPharm Receives USAN Approval for Asalhydromorphone” as Nonproprietary Name for Novel Prodrug Candidate, KP511 41
7.2.5 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report 42
7.2.6 Oct 06, 2017: Bruker Introduces Fungiplex Candida Assay into European Clinical Microbiology Markets 42
7.2.7 Oct 06, 2017: Integra LifeSciences launches Revize Collagen Matrix for Plastic and Reconstructive Surgery 45
7.2.8 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 45
7.3 Legal And Regulatory 47
7.3.1 Oct 09, 2017: USCOM cost effective replacement for ICU Ultrasound 47
7.4 Strategy And Business Planning 48
7.4.1 Jun 13, 2017: JRI Orthopaedics launches international centre of orthopaedic excellence 48
8 Appendix 50
8.1 Research Methodology 51
8.1.1 Coverage 51
8.1.2 Secondary Research 51
8.1.3 Primary Research 52
8.1.4 Market Modeling and Forecasting 53
8.1.5 Company Share Analysis 54
8.1.6 Distribution Share Analysis 55
8.1.7 Benchmarking 55
8.2 GlobalData Consulting 55
8.3 Contact Us 56
8.4 Disclaimer 56
List of Figure
1.2 List of Figures
Figure 1: Hip Reconstruction Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 7
Figure 2: Partial Hip Replacement Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 9
Figure 3: Primary Hip Replacement Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 11
Figure 4: Hip Reconstruction Market, United Kingdom, Volume (Units), 2015-2025 13
Figure 5: Partial Hip Replacement Market, United Kingdom, Volume (Units), 2015-2025 15
Figure 6: Primary Hip Replacement Market, United Kingdom, Volume (Units), 2015-2025 17
Figure 7: Hip Reconstruction Market, United Kingdom, Company Share (%) 2017 22
List of Table
1.1 List of Tables
Table 1: Hip Reconstruction Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 8
Table 2: Hip Reconstruction Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 8
Table 3: Partial Hip Replacement Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 10
Table 4: Partial Hip Replacement Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 10
Table 5: Primary Hip Replacement Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 12
Table 6: Primary Hip Replacement Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 12
Table 7: Hip Reconstruction Market, United Kingdom, Volume (Units), 2015-2020 14
Table 8: Hip Reconstruction Market, United Kingdom, Volume (Units), 2021-2025 14
Table 9: Partial Hip Replacement Market, United Kingdom, Volume (Units), 2015-2020 16
Table 10: Partial Hip Replacement Market, United Kingdom, Volume (Units), 2021-2025 16
Table 11: Primary Hip Replacement Market, United Kingdom, Volume (Units), 2015-2020 18
Table 12: Primary Hip Replacement Market, United Kingdom, Volume (Units), 2021-2025 18
Table 13: Hip Reconstruction Market, United Kingdom, Average Price (USD), 2015-2020 19
Table 14: Hip Reconstruction Market, United Kingdom, Average Price (USD), 2021-2025 20
Table 15: Hip Reconstruction Market, United Kingdom, Distribution Share by Revenue (USDm), USD Constant, 2017 21
Table 16: Hip Reconstruction Market, United Kingdom, Company Share by Revenue (USDm), USD Constant, 2017 23
Table 17: Hip Reconstruction Market Pipeline Products 26
Table 18: AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million 27
Table 19: Apposite Capital Acquries OrthoD from Riverside 29
Table 20: Elliott Management May Acquire Stake in Smith & Nephew 31
Table 21: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 53
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.